Business
ASX rises 0.9pc, buoyed by Victoria easing, vaccine development – The Australian Financial Review
The Australian sharemarket closed at a seven-month high on Monday as Victoria eased lockdown restrictions and on news of progress towards a COVID-19 vaccine.
“The crisis support has been significant and the tapering of such will present a drag. That said, the fiscal pivot is meaningful in size and focus. This combined with liquid and willing, monetary support allows for some calibration of an earnings recovery and more normalcy in the cycle.”
CSL led the market gains and a broadly firmer health sector with the British National Health Service deputy chief medical officer Jonathan Van-Tam suggesting the Oxford University vaccine being manufactured by …
-
General19 hours agoAustralia urged to spearhead regional carbon tariffs
-
Noosa News8 hours agoWinter cold snap heralds beginning of south-east Queensland dry season
-
General16 hours agoGippsland communities fear erosion protection not coping with rising tides
-
Business16 hours ago5 things to watch on the ASX 200 on Thursday 5 June 2025